Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes

Overview

Journal Ann Intern Med

Specialty General Medicine

Date 2023 Sep 18

PMID 37722124

Authors

Michael Fang

Justin B Echouffo-Tcheugui

Elizabeth Selvin

Affiliations

Soon will be listed here.

Citing Articles

Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.

Shah V, Agesen R, Bardtrum L, Christiansen E, Snaith J, Greenfield J J Diabetes Sci Technol. 2024; 19(2):321-331.

PMID: 39717993 PMC: 11669135. DOI: 10.1177/19322968241305647.

References

Holt R, DeVries J, Hess-Fischl A, Hirsch I, Kirkman M, Klupa T . The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021; 44(11):2589-2625. DOI: 10.2337/dci21-0043. View

Danne T, Garg S, Peters A, Buse J, Mathieu C, Pettus J . International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes Care. 2019; 42(6):1147-1154. PMC: 6973545. DOI: 10.2337/dc18-2316. View

Ahren B, Hirsch I, Pieber T, Mathieu C, Gomez-Peralta F, Hansen T . Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial. Diabetes Care. 2016; 39(10):1693-701. DOI: 10.2337/dc16-0690. View

Wallace A, Chang A, Shin J, Reider J, Echouffo-Tcheugui J, Grams M . Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2022; 107(5):1247-1256. PMC: 9016431. DOI: 10.1210/clinem/dgab927. View

Taylor S . The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients. Diabetes Care. 2020; 43(10):2330-2332. PMC: 8051261. DOI: 10.2337/dci20-0039. View